L. M. Ramondetta
University of Texas MD Anderson Cancer Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by L. M. Ramondetta.
American Journal of Obstetrics and Gynecology | 2011
Jennifer K. Burzawa; Kathleen M. Schmeler; Pamela T. Soliman; Larissa A. Meyer; Michael W. Bevers; Terri L. Pustilnik; Matthew L. Anderson; L. M. Ramondetta; Guillermo Tortolero-Luna; Diana L. Urbauer; Shine Chang; David M. Gershenson; Jubilee Brown; Karen H. Lu
OBJECTIVEnObesity and estrogen are strong risk factors for endometrial cancer (EC). Whereas diabetes also increases the risk, little is known about related insulin resistance (IR). The purpose of this study was to determine the prevalence of IR in newly diagnosed EC patients.nnnSTUDY DESIGNnEC patients from a large, metropolitan county were prospectively enrolled from 2005 to 2008. Fasting serum was analyzed for glucose and insulin. IR was defined as a history of diabetes or a quantitative insulin sensitivity check index (QUICKI) (1/[log fasting insulin + log fasting glucose]) value of less than 0.357.nnnRESULTSnAmong 99 patients, diabetes was present in 30, and an abnormal QUICKI was found in 36 additional patients. Increased risk of IR was significantly associated with higher body mass index (P < .001), lower socioeconomic status (P = .007), and nulliparity (P = .029).nnnCONCLUSIONnIR was highly prevalent in endometrial cancer patients, including nonobese women. Better characterization of metabolic risks in addition to obesity may provide avenues for targeted cancer prevention in the future.
Journal of Clinical Oncology | 2010
Diane C. Bodurka; Anuja Jhingran; L. M. Ramondetta; Patricia J. Eifel; C. H. Crane; A. T. Phan; D. Urbauer; Michael Frumovitz; L. S. Elting; Charlotte C. Sun
9056 Background: CG provide clinicians valuable information about treatment-related SE they see pts experience. As part of a larger study, we prospectively assessed the preferences of pts and CG fo...
Journal of Clinical Oncology | 2005
D. R. Crotzer; Judith K. Wolf; Russell Broaddus; L. M. Ramondetta
5107 Background: The purpose of this study was to compare molecular marker expression and clinical outcomes in patients treated for malignant mixed mesodermal tumor (MMMT) of the ovary with previou...
Journal of Clinical Oncology | 2008
Brian M. Slomovitz; Karen H. Lu; Taren Johnston; Mark F. Munsell; L. M. Ramondetta; Russell Broaddus; Robert L. Coleman; Cheryl L. Walker; David M. Gershenson; Thomas W. Burke; Judith K. Wolf
Gynecologic Oncology | 2006
L. M. Ramondetta; Charlotte C. Sun; Lisa M. Hollier; LaTasha Jarrett; Jody Folloder; Guillermo Tortolero-Luna; Alycia Hughes; Anuja Jhingran; Jubilee Brown
Archive | 2006
L. M. Ramondetta; Thomas W. Burke; Russell Broaddus; Anuja Jhingran
Journal of Clinical Oncology | 2007
Brian M. Slomovitz; L. M. Ramondetta; Taren Johnston; Karen H. Lu; Russell Broaddus; P. Muller; Revathy B. Iyer; Thomas W. Burke; David M. Gershenson; Judith K. Wolf
Gynecologic Oncology | 2011
Diane C. Bodurka; Charlotte C. Sun; Anuja Jhingran; Diana L. Urbauer; Charles Levenback; Patricia J. Eifel; L. M. Ramondetta; Pedro T. Ramirez; Michael Frumovitz; L. Schover
Gynecologic Oncology | 2012
Jennifer K. Burzawa; Kathleen M. Schmeler; Pamela T. Soliman; Robin A. Lacour; Larissa A. Meyer; Marilyn Huang; Michael W. Bevers; Michael Frumovitz; T. Pustilnik; Jubilee Brown; Matthew L. Anderson; L. M. Ramondetta; Guillermo Tortolero-Luna; Diana L. Urbauer; Qian Zhang; Russell Broaddus; S. Chang; David M. Gershenson; Karen H. Lu
Journal of Clinical Oncology | 2005
Brian M. Slomovitz; Robert L. Coleman; Pamela T. Soliman; L. M. Ramondetta; Judith K. Wolf; Charlotte C. Sun; David M. Gershenson; Thomas W. Burke; Karen H. Lu